Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IDYA
IDYA logo

IDYA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IDYA News

IDEAYA Biosciences Appoints New Chairman

4d agoNASDAQ.COM

IDEAYA Biosciences Elects New Chairman of the Board

4d agoPRnewswire

IDEAYA Biosciences Appoints New Chairman

4d agoNewsfilter

IDEAYA Launches Phase 1 Trial for IDE892 in Cancer Treatment

6d agoPRnewswire

IDEAYA Biosciences Launches IDE892 Clinical Trial for MTAP-Deleted Cancers

6d agoNewsfilter

IDEAYA Biosciences Completes Public Offering Raising $345 Million

Jun 10 2026PRnewswire

IDEAYA Biosciences Prices Public Offering at $27 per Share

Jun 09 2026NASDAQ.COM

IDEAYA Biosciences Raises $300M in Public Offering

Jun 09 2026seekingalpha

Tango Therapeutics Shares Surge Over 50% on Positive Trial Data

Jun 09 2026NASDAQ.COM

IDEAYA Biosciences Prices Public Offering of Common Stock

Jun 09 2026PRnewswire

IDEAYA Biosciences Prices Public Offering of Common Stock

Jun 09 2026Newsfilter

IDEAYA Plans $300 Million Public Offering of Common Stock

Jun 08 2026PRnewswire

IDEAYA Plans $300M Public Offering of Common Stock

Jun 08 2026seekingalpha

IDEAYA and Roche Collaborate on New Cancer Therapy Evaluation

Jun 03 2026seekingalpha

IDEAYA Partners with Roche for Clinical Trial of IDE892

Jun 03 2026PRnewswire

IDEAYA Enters Clinical Collaboration with Roche for IDE892 Evaluation

Jun 03 2026Newsfilter